Committees

Agenda for the 199th meeting of the Medicines Adverse Reactions Committee to be held on Thursday 12 September 2024, at 9 am

1.	MATTERS OF ADMINISTRATION
1.1	Welcome and apologies
1.2	Minutes and recommendations of the 198th MARC meeting
1.3	Declarations of potential competing interests
2.	MATTERS ARISING FROM THE NZ PHARMACOVIGILANCE CENTRE
2.1	CARM quarterly report
3.	PHARMACOVIGILANCE REPORTS
3.1	Matters referred to the MARC under section 36 of the Medicines Act 1981
	No items
3.2	Matters referred to the MARC by Medsafe
	3.2.1 Review of clozapine safety and monitoring requirements: clozapine-induced neutropenia and agranulocytosis
	3.2.2 Use of benzodiazepines for non-epilepsy indications during pregnancy and risk of miscarriage
	3.2.3 Anti-CD20 antibodies and pyoderma gangrenosum
	3.2.4 Empagliflozin and risk factors for ketoacidosis
4.	MEDSAFE PHARMACOVIGILANCE ACTIVITIES
4.1	Report on standing agenda items
4.2	Medsafe pharmacovigilance activities
4.3	Prescriber Update
4.4	Quarterly summary of recent safety communications
5.	OTHER BUSINESS